Literature DB >> 8993758

Profiles of cytokine production in recipients of transfer factors.

L Alvarez-Thull1, C H Kirkpatrick.   

Abstract

Transfer factors (TF) are proteins that transfer the ability to express cell-mediated immunity from immune donors to non-immune recipients. The mechanisms of these effects have not been defined. The experiments described in this report were undertaken to test the hypothesis that a mechanism through which the beneficial effects of TF are expressed in clinical situation is through "education" of the immune system to produce certain cytokines in response to antigenic stimulation. BALB/c mice were sensitized to Herpes simplexvirus (HSV) either by sublethal systemic or cutaneous infections by administration of a HSV-specific TF. One week later their spleen cells were collected and single cell suspensions were stimulated in vitro with irradiated HSV or concanavalin. A Culture supernatants were collected and assayed for content of IL-2, IL-4, IL-10 and IFN-g. Spleen cells from infected mice responded to concanavalin A and to HSV by secreting large amounts of IL-2 and IFN-g, modest amounts of IL-10, and no IL-4. Transfer factor recipients produced similar cytokine profiles in response to concavalin A. These mice, however, responded to HSV by secreting IFN-g, but no IL-2. Thus, TF treatment selectively affects cytokine production in response to antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8993758     DOI: 10.1007/bf02628657

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  5 in total

1.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  Preparation and properties of the specific anti-influenza virus transfer factor.

Authors:  Chongbi Li; Lihua Huang; Yanping Wang; Xiangle Li; Shaowei Liang; Yingna Zheng
Journal:  Head Face Med       Date:  2010-09-13       Impact factor: 2.151

3.  Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.

Authors:  Saul Oswaldo Lugo Reyes; Guadalupe Ramirez-Vazquez; Alonso Cruz Hernández; Edgar A Medina-Torres; Ana Belen Ramirez-Lopez; Corín España-Cabrera; Citlali A Hernandez-Lopez; Marco A Yamazaki-Nakashimada; Francisco J Espinosa-Rosales; Sara E Espinosa-Padilla; Chiharu Murata
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

4.  Immune response of mice with alveolar echinococcosis to therapy with transfer factor, alone and in combination with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2009-06-23       Impact factor: 2.289

5.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.